OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

NRXP — NRx Pharmaceuticals, Inc.

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 17, 2025

REVENUE

$242000

NET MARGIN

-2433.9%

EPS

-$0.27 +72.4%

FREE CASH FLOW

-$2.9M +28.2%

No summary has been written for this call yet.